

At times, meeting people feels like going to the theater. Conversations tend to revolve around the same topics and can sound so cliché that they seem scripted. Of course, it

Scientists at the Johns Hopkins University reversed hair whitening and loss associated with a high-fat, high-cholesterol diet by using an experimental compound in a mouse model [1]. The compound The

Another month, another series of great news items for healthy life extension enthusiasts! It’s hard to believe that July is already behind us and, with it, the first Lifespan.io conference

Today, we have an interview with Dr. João Pedro de Magalhães, the biogerontologist who created and runs senescence.info. How do you think we age; are we programmed to die, do

Today we have an interview with Dr. Aubrey de Grey from the SENS Research Foundation. This interview conducted by Yuri Deigin, CEO at Youthereum Genetics, was originally published in Russian language

Today, I would like to tell you two short stories describing what your far future might look like, depending on the choices that you—though not only you—will make in the

A common concern in the community is that the FDA, the EMA, and other bodies, such as WHO, do not classify aging as a disease and that this poses a

We interviewed Dr. Peter de Keizer, a researcher who is engaged in studying senescent cells and designing therapies to destroy them in order to delay and prevent age-related diseases. Cleara

You’re probably familiar with the feeling of slight disappointment that you may have when a good thing—say, a nice trip—is over. Just as you say that it’s too bad that

Recently, Reason of Fight Aging! pointed out psychological research revealing a certain conservatism in terms of what people consider to be the “ideal” levels of happiness, intelligence, longevity, and even

Senolytics have been in the news a great deal ever since van Deursen and his team conducted a landmark 2011 study showing that removing senescent cells could delay age-related ill

July is here, and our upcoming conference in New York City is only a handful of days away! About our NYC conference On the off chance you’ve missed the news

Today we are pleased to announce that UNITY Biotechnology is going into human clinical trials with the first true rejuvenation therapy that directly targets one of the processes of aging:

After meeting him at the Astana Global Challenges Summit 2018, we’ve kindly been granted an interview by Dr. Anthony Atala, M.D., Director of the Wake Forest Institute for Regenerative Medicine

Today, we conclude our two-part interview with Dr. Michael Fossel, you can find part one here. Changing tack a bit here, you talk a little bit in your book about

At times, meeting people feels like going to the theater. Conversations tend to revolve around the same topics and can sound so cliché that they seem scripted. Of course, it depends on the people—close friends tend to be far more genuine than that—but if you pay

Scientists at the Johns Hopkins University reversed hair whitening and loss associated with a high-fat, high-cholesterol diet by using an experimental compound in a mouse model [1]. The compound The experimental compound used by the researchers, called D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D–PDMP) acts by blocking the production of glucosphingolipids

Another month, another series of great news items for healthy life extension enthusiasts! It’s hard to believe that July is already behind us and, with it, the first Lifespan.io conference in New York City; let’s take a look back and review the past month before diving

Today, we have an interview with Dr. João Pedro de Magalhães, the biogerontologist who created and runs senescence.info. How do you think we age; are we programmed to die, do we wear out, or is the truth a mixture of both? I don’t think we wear

Today we have an interview with Dr. Aubrey de Grey from the SENS Research Foundation. This interview conducted by Yuri Deigin, CEO at Youthereum Genetics, was originally published in Russian language and he has kindly translated it into English so our audience can enjoy it too. Yuri:

Today, I would like to tell you two short stories describing what your far future might look like, depending on the choices that you—though not only you—will make in the near future. Feel free to leave a comment to let others know which one you’d rather

A common concern in the community is that the FDA, the EMA, and other bodies, such as WHO, do not classify aging as a disease and that this poses a problem for developing therapies that target aging. However, this is not really as serious an issue

We interviewed Dr. Peter de Keizer, a researcher who is engaged in studying senescent cells and designing therapies to destroy them in order to delay and prevent age-related diseases. Cleara Biotech is currently using his research to develop a senolytic peptide that accomplishes this via interfering

You’re probably familiar with the feeling of slight disappointment that you may have when a good thing—say, a nice trip—is over. Just as you say that it’s too bad that the experience is already finished, someone will probably say that you had a good time nonetheless;

Recently, Reason of Fight Aging! pointed out psychological research revealing a certain conservatism in terms of what people consider to be the “ideal” levels of happiness, intelligence, longevity, and even health. It probably doesn’t come as a surprise that significant numbers of people in the studies

Senolytics have been in the news a great deal ever since van Deursen and his team conducted a landmark 2011 study showing that removing senescent cells could delay age-related ill health in mice [1]. Since then, interest in what was once a niche topic has continued

July is here, and our upcoming conference in New York City is only a handful of days away! About our NYC conference On the off chance you’ve missed the news about it, Ending Age-Related Diseases: Investment Prospects & Advances in Research is our first conference to

Today we are pleased to announce that UNITY Biotechnology is going into human clinical trials with the first true rejuvenation therapy that directly targets one of the processes of aging: senescent cells. The quiet revolution In our collective imagination, revolutions start with a bang; however, more

After meeting him at the Astana Global Challenges Summit 2018, we’ve kindly been granted an interview by Dr. Anthony Atala, M.D., Director of the Wake Forest Institute for Regenerative Medicine and the W. Boyce Professor and Chair of Urology at Wake Forest University. Dr. Atala is

Today, we conclude our two-part interview with Dr. Michael Fossel, you can find part one here. Changing tack a bit here, you talk a little bit in your book about programmed human death; we’re basically programmed to die through evolution’s weird workings and you kind of